tiRNA-HAR contributes to ischemic myocardial injury via facilitating HuR-mediated stability of p53
Translational Research · 2025-06 · 280 · 17-28
DOI: 10.1016/j.trsl.2025.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2025-06. Verfasst von Changhao Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pha…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, ELAV-Like Protein 1, Myocardial Ischemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Cardiomyocyte death due to heart occlusion of coronary artery is the main driver to myocardial infarction (MI) and subsequent heart failure progression. tsRNA, a small RNA fragment from tRNA, has been shown to be implicated in many physiological and pathological processes by exerting different biological functions, but the roles of tsRNA in ischemic cardiac injury remain to be determined. The present study identified a hypoxia responsive-tiRNA (tiRNA-HAR) was markedly upregulated in ischemic mouse myocardium and hypoxic cardiomyocytes, respectively. Enforced expression of tiRNA-HAR by transfecting its mimic caused and aggravated, while knockdown of tiRNA-HAR mitigated cardiomyocyte apoptosis upon hypoxia. Cardiac specific knockdown of tiRNA-HAR mediated by AAV9 (adeno-associated virus 9) harboring an antisense oligonucleotide reduced cardiomyocytes apoptosis and improved cardiac function after MI. Mechanistically, tiRNA-HAR directly bound to HuR and enhanced the binding capacity of HuR and p53, thereby increasing the stability of p53. Silencing of HuR partially reversed the aggravative effects of tiRNA-HAR overexpression on cardiomyocyte apoptosis in the context of hypoxia. Collectively, our study reveals that tiRNA-HAR play a critical role in regulating cardiomyocytes apoptosis and cardiac injury via targeting HuR/p53 signaling axis after MI, and tiRNA-HAR might be a novel therapeutic target for treatment of ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Minist…
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Meteorological Sciences
- CAMS Innovation Fund for Medical Sciences
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Wang, C., Gao, Y., Liu, K., Zhang, Y., Sun, Z., Huang, M., Qu, Z., Yu, S., Han, J., Mei, Z., Dou, S., Jiang, J., Li, Y., Li, N., Huang, C., Dong, Y., Yang, B., & Du, W. (2025). tiRNA-HAR contributes to ischemic myocardial injury via facilitating HuR-mediated stability of p53. Translational Research, 280, 17-28. https://doi.org/10.1016/j.trsl.2025.04.002
Vancouver
Wang C, Gao Y, Liu K, Zhang Y, Sun Z, Huang M, et al. tiRNA-HAR contributes to ischemic myocardial injury via facilitating HuR-mediated stability of p53. Translational Research. 2025;280:17-28. doi:10.1016/j.trsl.2025.04.002
BibTeX
@article{Wang2025,
author = {Wang, Changhao and Gao, Yuelin and Liu, Kuiwu and Zhang, Yaozhi and Sun, Zhiyong and Huang, Min and Qu, Zhezhe and Yu, Shuting and Han, Jiaqi and Mei, Zhongting and Dou, Shunkang and Jiang, Jianhao and Li, Ying and Li, Na and Huang, Chuanhao and Dong, Yuechao and Yang, Baofeng and Du, Weijie},
title = {tiRNA-HAR contributes to ischemic myocardial injury via facilitating HuR-mediated stability of p53},
journal = {Translational Research},
year = {2025},
volume = {280},
pages = {17--28},
doi = {10.1016/j.trsl.2025.04.002}
}
EUVIMED